Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026 and Jul 2026.
- Largest single sale: $299K (5,889 shares) of Enliven Therapeutics, Inc. on Jul 6, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Director | Apr 10, 2024 | Jul 8, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 6, 2026, Enliven Therapeutics, Inc.: sold 10,000 shares for $505K, under a disclosed plan. 1 filing: 1
- Jun 5, 2026, Enliven Therapeutics, Inc.: sold 10,000 shares for $345K, under a disclosed plan. 1 filing: 1
- Dec 17, 2025, Enliven Therapeutics, Inc.: 15,958 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.